Delivery Order SPE2DB22D2214-SPE2DB23FS5QD
Award Date 7/24/23
Potential Completion Date 7/25/23
Potential Value $833
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $803.76 delivery order to Amerisourcebergen Drug Corporation for the provision of 4562099666 XYOSTED 75 MG/0.5 ML auto-injectors. The firm fixed-price contract calls for the delivery of 0.5mL auto-injectors to a location in Conshohocken, Pennsylvania by September 11, 2023 in support of DLA programs. Amerisourcebergen will perform as the prime contractor, with no major subcontractors mentioned. The delivery order was issued against an unspecified DLA-wide...
- The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561306942 XYOSTED 75 MG/0.5 ML auto-injectors. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 0.5ml auto-injectors to a location in Conshohocken, Pennsylvania by June 21, 2023 in support of the Department of Defense's medical supply needs. Amerisourcebergen will perform as the...
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,257 to Amerisourcebergen Drug Corporation for the provision of XYOSTED 75 MG/0.5 ML auto-injectors to be delivered to a location in Conshohocken, Pennsylvania. The firm fixed price order is for a single day of performance between July 25-26, 2023 to supply the specified pharmaceutical product. No additional details were provided regarding quantities, though the Defense Logistics Agency utilizes various...
- The Defense Logistics Agency awarded a $2,127 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561419851 XYOSTED 75 MG/0.5 ML auto-injectors. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period in early July 2023. No set-aside...
- The Defense Logistics Agency awarded a $1,759.94 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 4561356848 XYOSTED 75 MG/0.5 ML auto-injectors. The contract calls for the delivery of 0.5 milliliter auto-injection devices to a location in Conshohocken, Pennsylvania. The fixed-price order is valued at one thousand seven hundred fifty-nine dollars and ninety-four cents and supports the Defense Logistics Agency's medical supply needs from June 27, 2023 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 100 mg/0.5 mL XYOSTED auto-injectors. The $1,309.95 order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of January 16, 2024. This delivery order was placed under an existing indefinite delivery contract between AmerisourceBergen Drug Corp and DLA to...
- The Defense Logistics Agency awarded a delivery order valued at $1,464.31 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. This competitively awarded, firm fixed-price contract was issued on June 4, 2025, with an ultimate completion date of June 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award, indicating open competition among qualified...
- The Defense Logistics Agency awarded a $1,831 firm fixed price delivery order to Amerisourcebergen Drug Corporation for XYOSTED 100 MG/0.5 ML auto-injectors. The delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 26, 2023. No subcontractors or set-aside designations were identified. This order...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,323.55 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 mL auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is unset-aside and represents a child order under a larger vehicle supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,150.15 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. The contract, which is non-set-aside and competitively awarded, was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order operates under...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB23FS5QDDelivery Order
The Defense Logistics Agency awarded a $833 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561586473 XYOSTED 75 MG/0.5 ML auto-injectors. The firm fixed-price order calls for the delivery of 0.5mL auto-injectors to a location in Conshohocken, Pennsylvania by July 25, 2023 in support of DLA programs. Amerisourcebergen will perform as the prime contractor, with no major subcontractors indicated. The delivery order was issued against an unidentified DLA-wide contract vehicle and has no set-aside designation. This order for auto-injectable drug products is consistent with DLA's mission to provide medical supplies and pharmaceuticals to support military treatment facilities worldwide.
Generated 12/20/23, 11:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $833 | 7/24/23 |